RN7SKP3: A Promising Drug Target / Biomarker (G100873847)

Target Name: RN7SKP3

NCBI ID: G100873847

RN7SKP3

Other Name(s): RN7SK pseudogene 3 | RNA, 7SK small nuclear pseudogene 3

RN7SKP3: A Promising Drug Target / Biomarker

The RNA-protein complex known as RN7SKP3 has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and psychiatric disorders. This protein plays a crucial role in regulating the translation of RNA into proteins, which are essential for the development and progression of these diseases. In this article, we will explore the structure, function, and potential therapeutic applications of RN7SKP3.

Structure

The RNA-protein complex of RN7SKP3 consists of the protein RN7SKP3 and the RNA molecule itself. The protein has a unique structure that is composed of multiple domains, including a nucleotide-binding domain (NBD), a conserved core domain, and a transmembrane region (TMR).

The NBD is the region of the protein that binds to the RNA molecule. It is composed of a nucleotide-binding oligomer that consists of a core RNA-binding site and a terminal 5'-end region. The core RNA-binding site is the region where the RNA molecule binds to the protein, and it is known as the binding site A (BSA). The BSA is the most stable part of the NBD, and it plays a crucial role in the stability and stability of the RNA-protein complex.

The conserved core domain is the region of the protein that is common to all RNA-protein complexes. It is composed of a series of conserved amino acid residues that are important for the stability and stability of the complex. The transmembrane region (TMR) is the region of the protein that spans the membrane of the cell. It is composed of a series of transmembrane amino acids that are responsible for the protein's solubility and its ability to interact with other proteins.

Function

The function of RN7SKP3 is to regulate the translation of RNA into proteins. It does this by binding to the RNA molecule and preventing it from being translated into a protein. This is done by the conserved core domain, which contains the ATP-binding site (ABS) and the GTP-binding site (GBS), which are essential for the stability and stability of the RNA-protein complex.

The RNA-protein complex of RN7SKP3 is highly stable and can be isolated from other RNA-protein complexes using techniques such as affinity purification. This stability is important for the use of RN7SKP3 as a drug target because it allows it to remain in the target cell long enough to interact with the RNA molecule and prevent it from being translated into a protein.

Potential Therapeutic Applications

The potential therapeutic applications of RN7SKP3 are vast and varied. One of its greatest strengths is its ability to target RNA molecules that are involved in the development and progression of diseases.

For example, RN7SKP3 has been shown to play a role in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. Studies have shown that the levels of RN7SKP3 in the brains of individuals with these diseases are significantly higher than in healthy individuals. This suggests that RN7SKP3 may be a potential therapeutic target for these diseases.

In addition to its potential role in neurodegenerative diseases, RN7SKP3 has also been shown to be involved in the development of cancer. Studies have shown that the levels of RN7SKP3 in the tissues of individuals with cancer are higher than in healthy individuals. This suggests that RN7SKP3 may be a potential therapeutic target for cancer.

Another potential therapeutic application of RN7SKP3 is its potential as a biomarker. The stability and stability of the RNA-protein complex of RN7SKP3 make it an attractive candidate for use as a biomarker for various diseases. For example, the levels of RN7SKP3 in the tissues of individuals with certain diseases, such as

Protein Name: RN7SK Pseudogene 3

The "RN7SKP3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RN7SKP3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets